Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Select Drug Profiles
FDA Approvals
FDA Update
Read More
Aetna Examines Impact of Site of Service on Chemotherapy Cost
Caroline Helwick
Read More
Treating with Checkpoint Inhibitors—Figure $1 Million per Patient
Audrey Andrews
Read More
Researchers Dissect the Cost of Targeted Agents
Caroline Helwick
Read More
Bevacizumab Wins Cost-Effectiveness Contest in First-Line Metastatic Colorectal Cancer
Caroline Helwick
Read More
Will Necitumumab Be Cost-Effective?
Caroline Helwick
Read More
UnitedHealthcare’s Episode-Based Payment Model Program Cuts Cost
Caroline Helwick
Read More
Care Pathway for NSCLC Cuts Chemotherapy Cost
Wayne Kuznar
Read More
Oral Nicotinamide Prevents Common Skin Cancers in High-Risk Patients, Reduces Costs
Phoebe Starr
Read More
FDA Approvals
CAR-T Cells: The Transplants of the Future
Chase Doyle
Read More
125
126
127
128
129
130
131
Page 128 of 244
Results 1271 - 1280 of 2434